Testicular Adrenal Rest Tumors: Current Insights on Prevalence, Characteristics, Origin, and Treatment
The DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.
Abstract
This review provides the reader with current insights on testicular adrenal rest tumors (TARTs), a complication in male patients with congenital adrenal hyperplasia (CAH). In recent studies, an overall TART prevalence of 40% (range, 14% to 89%) in classic patients with CAH is found. Reported differences are mainly caused by the method of detection and the selected patient population. Biochemically, histologically, and molecularly, TARTs exhibit particular adrenal characteristics and were therefore thought to originate from aberrant adrenal cells. More recently, TARTs have been found to also exhibit testicular characteristics. This has led to the hypothesis of pluripotent cells as the origin of TARTs. High concentrations of ACTH could cause hyperplasia of these pluripotent cells, as TARTs appear to be associated with poor hormonal control with concomitant elevated ACTH. Unfortunately, as yet there are no methods to prevent the development of TARTs, nor are there guidelines to treat patients with TARTs. Intensified glucocorticoid treatment could improve fertility status in some cases, although studies report contradicting results. TARTs can also lead to irreversible testicular damage, and therefore semen cryopreservation could be offered to patients with TARTs. Further research should focus on the etiology and pharmacological treatment to prevent TART development or to treat TARTs and improve the fertility status of patients with TARTs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These benign, bilateral tumours are histologically similar to adrenocortical cells and are thought to originate from pluripotent cells or from cells of adrenal origin, which descend with the testis during embryogenesis and proliferate with ACTH stimulation98,99.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [98]
In the citing paper
“These benign, bilateral tumours are histologically similar to adrenocortical cells and are thought to originate from pluripotent cells or from cells of adrenal origin, which descend with the testis during embryogenesis and proliferate with ACTH stimulation98,99.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [98]
Citations
Cites
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Schoenwolf, G. C., Bleyl, S. B., Brauer, P. R., & Francis‐West, P. H. (2014) · Cited by 401
Thomas, D. (2009) · Osteopathische Medizin · doi:10.1016/j.ostmed.2008.12.005 · Cited by 341
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
Finkielstain, G. P., Kim, M. S., Sinaii, N., Nishitani, M., Van Ryzin, C., Hill, S. C., Reynolds, J. C., Hanna, R. M., & Merke, D. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2102 · Cited by 313
Genetics of congenital adrenal hyperplasia
Krone, N., & Arlt, W. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.014 · Cited by 312
Stikkelbroeck, N. M. M. L., Otten, B. J., Pasic, A., Jager, G. J., Sweep, C. G. J. F., Noordam, K., & Hermus, A. R. M. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8090 · Cited by 305
Self-citationJones, T. D., Ulbright, T. M., Eble, J. N., Baldridge, L. A., & Cheng, L. (2004) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200407000-00014 · Cited by 283
Role of the GATA Family of Transcription Factors in Endocrine Development, Function, and Disease
Viger, R. S., Guittot, S. M., Anttonen, M., Wilson, D. B., & Heikinheimo, M. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0513 · Cited by 270
Cited by
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationOverview of the 2022 WHO Classification of Adrenal Cortical Tumors
Mete, O., Erickson, L. A., Juhlin, C. C., de Krijger, R. R., Sasano, H., Volante, M., & Papotti, M. G. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09710-8 · Cited by 343
“, renal cell carcinoma and hepatocellular carcinoma) [23, 24, 53, 57, 58].”
BackgroundCongenital adrenal hyperplasia
Auer, M. K., Nordenström, A., Lajic, S., & Reisch, N. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01330-7 · Cited by 215
Management challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Kallali, W., Gray, E., Mehdi, M. Z., Lindsay, R. S., Metherell, L., Buonocore, F., Suntharalingham, J. P., Achermann, J. C., & Donaldson, M. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0696 · Cited by 46
Long-Term Outcomes of Congenital Adrenal Hyperplasia
Nordenström, A., Lajić, S., & Falhammar, H. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1528 · Cited by 49
“ACTH has been proposed to be the most important stimulant of adrenal rest tumors [72].”
InfluentialChallenges in treatment of patients with non-classic congenital adrenal hyperplasia
Adriaansen, B. P. H., Schröder, M. A. M., Span, P. N., Sweep, F. C. G. J., van Herwaarden, A. E., & der Grinten, H. L. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1064024 · Cited by 51
Self-citationCorcioni, B., Renzulli, M., Marasco, G., Baronio, F., Gambineri, A., Ricciardi, D., Ortolano, R., Farina, D., Gaudiano, C., Cassio, A., et al. (2021) · Translational Andrology and Urology · doi:10.21037/tau-20-998 · Cited by 42
“Regardless of the different etiological theories (8-10), adrenocorticotropic hormone (ACTH) has been recognized as the most important factor promoting the development of TARTs (1,11,12).”
Pozza, C., Tenuta, M., Sesti, F. F., Bertolotto, M., Huang, D. Y., Sidhu, P. S., Maggi, M., Isidori, A. M., & Lotti, F. (2023) · Cancers · doi:10.3390/cancers15225332 · Cited by 37
“Generally, TARTs are bilateral and non-palpable due to their occurrence near or within the mediastinum, and a firm mass can be palpated only when the lesion exceeds 2 cm in diameter [41].”
BackgroundInfluentialMedical management of non-obstructive azoospermia: A systematic review
Alkandari, M. H., & Zini, A. S. (2021) · Arab Journal of Urology · doi:10.1080/2090598x.2021.1956233 · Cited by 40
“However, the most common cause of infertility in patients with CAH is the development of TARTs in ~40% of patients [11].”
BackgroundUslar, T., Olmos, R. I., Martínez‐Aguayo, A., & Baudrand, R. F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093128 · Cited by 49
“Surgery is only indicated for cases of severe pain complaints, as it has been proven ineffective in restoring fertility by retrospective cohorts [25].”
BackgroundTesticular adrenal rest tumors in children with congenital adrenal hyperplasia
Al-Ghamdi, W. M., Shazly, M. A., & Al-Agha, A. E. (2021) · Saudi Medical Journal · doi:10.15537/smj.2021.42.9.20210257 · Cited by 33
Sarafoglou, K., Merke, D. P., Reisch, N., der Grinten, H. L. C., Falhammar, H., & Auchus, R. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad134 · Cited by 35
Novel treatments for congenital adrenal hyperplasia
Schröder, M. A. M., & der Grinten, H. L. C. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09717-w · Cited by 34
“In males with classic CAH and poor hormonal control, development of testicular adrenal rest tumors (TART) can already occur in early puberty or even during childhood [28].”
BackgroundResidual Corticosteroid Production in Autoimmune Addison Disease
Sævik, Å. B., Åkerman, A.-K., Methlie, P., Quinkler, M., Jørgensen, A. P., Höybye, C., Debowska, A. J., Nedrebø, B. G., Dahle, A. L., Carlsen, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa256 · Cited by 28
“The observed male preponderance in residual GC production opens for a tantalizing link to hormone-producing testicular adrenal rest tumors (TARTs), as seen in approximately 40% of men with congenital adrenal hyperplasia (29).”
Adrenal Rests in the Uro-genital Tract of an Adult Population
Falco, E. C., Daniele, L., Metović, J., Bollito, E., Rosa, G. D., Volante, M., & Papotti, M. G. (2021) · Endocrine Pathology · doi:10.1007/s12022-021-09685-y · Cited by 24
Long‐term health consequences of congenital adrenal hyperplasia
Pofi, R., Ji, X., Krone, N. P., & Tomlinson, J. (2023) · Clinical Endocrinology · doi:10.1111/cen.14967 · Cited by 30
“25 58 – 61 Currently, there are no definitive guidelines for treating or preventing TARTs.”
InfluentialProduction of 11-Oxygenated Androgens by Testicular Adrenal Rest Tumors
Schröder, M. A. M., Turcu, A. F., O’Day, P., van Herwaarden, A. E., Span, P. N., Auchus, R. J., Sweep, F. C. G. J., & der Grinten, H. L. C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab598 · Cited by 24
Self-citationCongenital Adrenal Hyperplasia
Fraga, N. R., Minaeian, N., & Kim, M. S. (2024) · Pediatrics in Review · doi:10.1542/pir.2022-005617 · Cited by 30
Non-Canonical Effects of ACTH: Insights Into Adrenal Insufficiency
Hasenmajer, V., Bonaventura, I., Minnetti, M., Sada, V., Sbardella, E., & Isidori, A. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.701263 · Cited by 29
Lajić, S., Karlsson, L., Zetterström, R. H., Falhammar, H., & Nordenström, A. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6030068 · Cited by 25
“Fertility in males with CAH is impaired [26,27], mainly due to hyper- or hypogonadotropic hypogonadism and testicular adrenal rest tumors (TARTs) [28].”
BackgroundUltrasonography of the scrotum: Revisiting a classic technique
Tsili, A. C., Bougia, C. Κ., Pappa, O., & Argyropoulou, M. I. (2021) · European Journal of Radiology · doi:10.1016/j.ejrad.2021.110000 · Cited by 21
Guo, X., Zhang, Y., Yu, Y., Zhang, L., Ullah, K., Ji, M., Jin, B., & Shu, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.982953 · Cited by 23
Bachelot, A., Lapoirie, M., Dulon, J., Leban, M., Renard Penna, R., & Touraine, P. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-0787 · Cited by 19
Testicular Adrenal Rest Tumors in Patients with Congenital Adrenal Hyperplasia: A Case Series
Yıldırımçakar, D., Altıncık, A., Öcal, M., & Özhan, B. (2020) · Trends in Pediatrics · doi:10.5222/tp.2020.87587 · Cited by 19
TSYRETOROVA, S. (2022) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2022-11-3-115-117 · Cited by 18
Effect of cholecalciferol supplementation on the clinical course of hospitalized COVID 19 patients
Mikhailova, A. A., Lagutina, D. I., & Golovatyuk, K. A. (2022) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2022-11-3-119-121 · Cited by 18
Burman, P., Falhammar, H., Waldenström, E., Sundin, A., & Bitzèn, U. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa870 · Cited by 19
Adriaansen, B. P. H., Kamphuis, J. S., Schröder, M. A. M., Olthaar, A. J., Bock, C., Brandt, A. M., Stikkelbroeck, N. M. M. L., Lentjes, E. G. W. M., Span, P. N., Sweep, F. C. G. J., et al. (2022) · Clinical Endocrinology · doi:10.1111/cen.14690 · Cited by 18
“In addition, elevated levels of ACTH may lead to the formation of testicular adrenal rest tumours.(2) Patients with mutations leading to a (near) complete loss of enzymatic function, usually associated with <1% residual activity, also have decreased concentrations of aldosterone, leading to a neonatal salt loss that m…”
BackgroundSelf-citationder Grinten, H. L. C., Adriaansen, B. P. H., & Falhammar, H. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae718 · Cited by 19
Management aspects of congenital adrenal hyperplasia during adolescence and transition to adult care
Balagamage, C., Arshad, A., Elhassan, Y., Said, W. B., Krone, R. E., Gleeson, H. K., & Idkowiak, J. (2023) · Clinical Endocrinology · doi:10.1111/cen.14992 · Cited by 19
“72 Since Leydig ‐ cell tumours, in contrast to TARTs, are more likely to progress to cancer in adulthood, 99,100 surgery is the treatment of choice, in contrast to TARTs, which are currently only removed if they become symptomatic due to pain or mass ‐ related discomfort.”
InfluentialJha, S., El‐Maouche, D., Marko, J., Mallappa, A., Veeraraghavan, P., & Merke, D. P. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00227 · Cited by 16
“The prevalence of TARTs among men with classic CAH is estimated to be ;40% (range 14% to 89%) [3].”
BackgroundKarlekar, M. P., Sarathi, V., Lila, A. R., Rai, K., Arya, S., Bhandare, V. V., Atluri, S., Patil, V. A., Ramteke‐Jadhav, S., Shah, N. S., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14376 · Cited by 17
Emergence of Ectopic Adrenal Tissues-What are the Probable Mechanisms?
Tarçın, G., & Ercan, O. (2021) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2021.2021.0148 · Cited by 15
“There are a number of studies and observations supporting the role of ACTH in the development of testicular adrenal rest tumors, one of which has been mentioned above, in patients with congenital adrenal hyperplasia.”
BackgroundInfluentialTresoldi, A. S., Betella, N., Hasenmajer, V., Pozza, C., Vena, W., Fiamengo, B., Negri, L., Cappa, M., Lania, A. G., Lenzi, A., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01362-x · Cited by 14
Sexually transmitted doping: The impact of urine contamination of semen
Handelsman, D. J., Bacha, F., DeBono, M., Sleiman, S., & Janu, M. R. (2022) · Drug Testing and Analysis · doi:10.1002/dta.3331 · Cited by 14
“plasma but without entering seminal fluid from exogenous sources.(23,24) Exogenous synthetic steroids measured in seminal plasma are reported for a synthetic progestin dienogest(11) together”
BackgroundSchröder, M. A. M., Neacşu, M., Adriaansen, B. P. H., Sweep, F. C. G. J., Ahmed, S. F., Ali, S., Bachega, T. A. S. S., Baronio, F., Birkebæk, N., de Bruin, C., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad143 · Cited by 15
Self-citationKolli, V., da Cunha, I. W., Kim, S., Iben, J., Mallappa, A., Li, T., Gaynor, A., Coon, S. L., Quezado, M., & Merke, D. P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.730947 · Cited by 13
“Previous studies have described TARTs to be well-demarcated from surrounding testicular tissue andmicroscopically to contain large polygonal cells with abundant granular eosinophilic cytoplasm (16, 18, 19).”
BackgroundBouzidi, L., Triki, M., Charfi, S., Ameur, H. B., Dhaou, M. B., Bouaziz, T., & Boudawara, T. S. (2021) · Pediatric and Developmental Pathology · doi:10.1177/1093526620980614 · Cited by 13
“However, by analogy with TART, no cases of malignancy have been reported until now.(17) In conclusion, OART should be considered when ovarian masses are detected in women with CAH especially if they are not compliant with their treatment.”
BackgroundKim, M. S., Koppin, C. M., Mohan, P., Goodarzian, F., Ross, H., Geffner, M. E., Filippo, R. D., & Kokorowski, P. K. (2019) · Hormone Research in Paediatrics · doi:10.1159/000504135 · Cited by 11
“Patients with TART also have higher 65 concentrations of steroid production including 17-hydroxyprogesterone and androstenedione [9].”
BackgroundLim, S. G., Lee, Y. A., Jang, H. N., Kong, S. H., Ahn, C. H., Kim, S. W., Shin, C. H., & Kim, J. H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.761258 · Cited by 12
“org 6 The presence of TART is the main factor of male infertility since it blocks the seminiferous tubules and leads to Leydig cell failure, which has a reported prevalence of around 37% (14–86%) depending on age and genotype (5, 6, 19, 30).”
BackgroundTranscriptional comparison of testicular adrenal rest tumors with fetal and adult tissues
Schröder, M. A. M., Sweep, F. C. G. J., van Herwaarden, A. E., Mitchell, R. T., Eliveld, J., van Pelt, A. M. M., Rowan, A. E., Korbie, D. J., Stikkelbroeck, N. M. M. L., der Grinten, H. L. C., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0143 · Cited by 11
“The variation between TART samples, and more specifically between the TART samples of different patients, might explain the contradicting results of previous case reports where TART with (3) or without (5) testis-specific characteristics have been reported.”
BackgroundResultInfluentialSelf-citationJohannsen, T. H., Albrethsen, J., Neocleous, V., Baronio, F., Cools, M., Aksglaede, L., Jørgensen, N., Christiansen, P., Toumba, M., Fanis, P., et al. (2023) · Endocrine Connections · doi:10.1530/ec-23-0073 · Cited by 9
Clinical and biochemical footprints of inherited metabolic diseases. VIII. Neoplasias
Serrano, T. J., Blau, N., & Ferreira, C. R. (2022) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2022.03.011 · Cited by 10
Genotype of congenital adrenal hyperplasia patients with testicular adrenal rest tumor
Aycan, Z., Keskın, M., Lafcı, N. G., Erdeve, Ş. S., Baş, F., Poyrazoğlu, Ş., Öztürk, P., Parlak, M., Ercan, O., Güran, T., et al. (2022) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2022.104654 · Cited by 12
Rare forms of genetic steroidogenic defects affecting the gonads and adrenals
Boettcher, C., & Flück, C. E. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101593 · Cited by 12
Šáhó, R., Dolžan, V., Tanšek, M. Ž., Pastorakova, A., Petrovič, R., Knapková, M., Podkrajšek, K. T., Omladič, J. Š., Bertok, S., Stefanija, M. A., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1134133 · Cited by 10
“TARTs can cause severe pain complaints and irreversible damage to the testicular parenchyma, leading to infertility (13).”
BackgroundMedical treatment prior to micro-TESE
Dasgupta, S., Le, T. V., Rambhatla, A., Shah, R. S., & Agarwal, A. K. (2024) · Asian Journal of Andrology · doi:10.4103/aja202492 · Cited by 11
“21,22,32 Therefore, in these cases, micro-TESE can be avoided, and natural conception is possible once spermatogenesis is regained.”
Cinque, A. D., Corcioni, B., Rossi, M. S., Franceschelli, A., Colombo, F., Golfieri, R., Renzulli, M., & Gaudiano, C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.610384 · Cited by 8
Prenatal and Pregnancy Management of Congenital Adrenal Hyperplasia
Nowotny, H. F., Tschaidse, L., Auer, M. K., & Reisch, N. (2024) · Clinical Endocrinology · doi:10.1111/cen.15131 · Cited by 13
Bancos, I., Kim, H., Cheng, H. K.-H., Rodríguez-Lee, M., Coope, H., Cicero, S., Goldsmith, H., Lin, V. H., & Jeha, G. S. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2450423 · Cited by 9
“The estimated prevalence of TARTs is approximately 40%, with reported prevalences ranging from 14% to 86% depending on age, disease control, and frequency and method of detection [49,50].”
Huneif, M. A., Mutairi, M. A., Alhazmy, Z. H., AlOsaimi, F. K., AlShoomi, A. M., Alghofely, M. A., & Alsaheel, A. Y. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0291 · Cited by 7
Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia
Adriaansen, B. P. H., Utari, A., Olthaar, A. J., van der Steen, R. C. B. M., Pijnenburg-Kleizen, K. J., Berkenbosch, L., Span, P. N., Sweep, F. C. G. J., der Grinten, H. L. C., & van Herwaarden, A. E. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae591 · Cited by 7
Self-citationYu, L., Chen, P., Zhu, W., Sun, J., & Li, S. (2021) · BMC Pediatrics · doi:10.1186/s12887-021-02883-x · Cited by 7
“In Magnetic Resonance Imaging(MRI), TARTs characterized with hypointensity on T2-W images, and hyperintensity or iso-intensity on T1-W images and lesion margins were clearly defined[5].”
BackgroundInfluentialFertility and pregnancy in adrenal insufficiency
Green, D., Dineen, R., O’Reilly, M., & Sherlock, M. (2023) · Endocrine Connections · doi:10.1530/ec-23-0088 · Cited by 13
“Leydig cell tumours are predominantly unilateral compared to TARTs which are usually bilateral and exhibit characteristic histologic structures called Reinke crystalloids, which are never found in TARTs ( 91 ).”
BackgroundTuladhar, S., Katwal, S., Joshi, H. O., Yadav, B., Bhusal, A., & Bhandari, S. (2023) · Radiology Case Reports · doi:10.1016/j.radcr.2023.09.006 · Cited by 5
Imaging Features of Ectopic Tissues and Their Complications: Embryologic and Anatomic Approach
Kurokawa, M., Kurokawa, R., Tamura, K., Baba, A., Ota, Y., Nakaya, M., Yokoyama, K., Kim, J., Moritani, T., & Abe, O. (2023) · Radiographics · doi:10.1148/rg.220111 · Cited by 7
Elevated periprostatic androgens, sneaky testosterone and its implications
Bitaraf, M., Ramasamy, R., Punnen, S., & Sharifi, N. (2024) · Nature Reviews Urology · doi:10.1038/s41585-024-00878-8 · Cited by 4
“This observation provides biochemical evidence to support the testicular origin of the enriched periprostatic testosterone 8,41,42 .”
Langzeitmorbidität beim adrenogenitalen Syndrom
Tschaidse, L., Quitter, F., Hübner, A., & Reisch, N. (2022) · Der Internist · doi:10.1007/s00108-021-01223-6 · Cited by 4
Alyamani, M., Michael, P., Hettel, D. R., Thomas, L. J., Lundy, S. D., Berk, M., Patel, M., Li, J., Rashidi, H., McKenney, J. K., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci171117 · Cited by 4
“Although other origins of steroidogenesis are possible, the tracking of dorsal/peripheral ratios of T with 17-OH-pro-gesterone, a well-established marker of gonadal function, supports testicular steroidogenesis as the most probable source (13, 19).”
Trahmono, T., Wahyudi, I., Rodjani, A., Situmorang, G. R., & Marzuki, N. S. (2020) · Research and Reports in Urology · doi:10.2147/rru.s277216 · Cited by 4
Able, C. A., Liao, B., Farran, E., Abid, A. M., & Farhan, B. (2022) · Urology Case Reports · doi:10.1016/j.eucr.2022.102247 · Cited by 4
Abawi, O., Sommer, G., Größl, M., Halbsguth, U., du Toit, T., Hannema, S. E., de Bruin, C., Charmandari, E., van den Akker, E. L. T., Leichtle, A. B., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf121 · Cited by 3
Fertility in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a review
Roszkowska, Z., Bobrowicz, M., Betlejewska, J., Hubska, J., Rak, B., & Ambroziak, U. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1682341 · Cited by 5
How to manage puberty and prevent fertility disorders in men with CAH?
der Grinten, H. L. C. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.04.005 · Cited by 4
Ortolano, R., Cassio, A., Alqaisi, R. S., Candela, E., Natale, V. D., Assirelli, V., Bernardini, L., Bortolamedi, E., Cantarelli, E., Corcioni, B., et al. (2023) · Children · doi:10.3390/children10091457 · Cited by 4
“Nevertheless, several studies do not confirm this cause-effect hypothesis [4,15,17], possibly due to the paucity of the patients enrolled.”
BackgroundAuer, M. K., Büyükerzurmulu, D., Lottspeich, C., Bidlingmaier, M., Rieger, E., Nowotny, H. F., Tschaidse, L., Auchus, R. J., & Reisch, N. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae112 · Cited by 3
Garcia, C., Dusaud, M., Chiron, P., Sollier, M., Nassouri, S., Groussin, L., Sibony, M., Goursaud, C., Roucher‐Boulez, F., & Bordier, L. (2021) · Case Reports in Endocrinology · doi:10.1155/2021/5889007 · Cited by 3
“Indeed, TARTs should not be operated except in cases of pain or discomfort due to their high volume [7].”
InfluentialA new recipe for TARTs? One step closer in identifying the origin of testicular adrenal rest tumours
Guasti, L., & Pittaway, J. F. H. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0784 · Cited by 3
Ferreux, L., Boumerdassi, Y., Dulioust, E., BERTAGNA, X. Y., Roucher‐Boulez, F., Bourdon, M., Thiounn, N., & Patrat, C. (2023) · Basic and Clinical Andrology · doi:10.1186/s12610-022-00176-6 · Cited by 3
Hamidi, O., Auchus, R. J., Correa, R. R., Levine, A. C., Wierman, M. E., Hartzell, A. L., Lin, V. H., & Bancos, I. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag147 · Cited by 4
Leukocyte Telomere Length in Children With Congenital Adrenal Hyperplasia
Raftopoulou, C., Abawi, O., Sommer, G., Binou, M., Paltoglou, G., Flück, C. E., van den Akker, E. L. T., & Charmandari, E. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac560 · Cited by 2
Carrière, C., Sarfati, C., Téjédor, I., Dulon, J., Chakhtoura, Z., Courtillot, C., & Bachelot, A. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.04.007 · Cited by 3
Zakharov, A. D. (2022) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2022-11-3-122-124 · Cited by 2
Rivera-Hernández, A. D. J., Jimenez-Osorio, M., Rodríguez-Mencias, J. P., Escamilla-Castañeda, K. M., Madrigal-González, M. M., & Zurita‐Cruz, J. N. (2023) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2023.03.028 · Cited by 2
Infertility risk assessment with ultrasound in congenital adrenal hyperplasia male patients
Wang, Z., Wang, R., Wang, X., Zheng, S., Li, M., Yu, Y., Liu, Z., Sun, S., & Zhan, W. (2024) · Scientific Reports · doi:10.1038/s41598-024-62954-8 · Cited by 4
When Diagnosis Takes a Turn: A Case Series on Testicular Adrenal Rest Tumor/Leydig Cell Tumor
Arshad, M., Khawaja, S., Ayub, M., Siddiqi, A. I., & Shafiq, W. (2024) · Cureus · doi:10.7759/cureus.63014 · Cited by 2
Testicular Adrenal Rest Tumour (TART) or Testicular Malignancy: A Clinical Dilemma
Roy, M., Roy, A. K., Chatterjee, T., & Bansal, S. K. (2020) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2020_001669 · Cited by 2
Pancreas, Adrenal Glands, and Retroperitoneum
Hryhorczuk, A. L., & Paltiel, H. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-56802-3_14 · Cited by 2
Testicular Adrenal Rest Tumors in a Patient With Congenital Adrenal Hyperplasia
Yu, S.-Y., & Freed, K. M. (2022) · Cureus · doi:10.7759/cureus.28350 · Cited by 2
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Liang, M. C., Kokorowski, P. K., Tseng, T., Koppin, C. M., & Geffner, M. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-14881-1_59 · Cited by 2
Ilboudo, A., Sagna, Y., Dubreuil, S., Touraine, P. A., & Courtillot, C. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.02.003 · Cited by 1
Patient and Parent Perspectives on Testicular Adrenal Rest Tumors in Congenital Adrenal Hyperplasia
Nebesio, T. D., Kim, M. S., Szymanski, K. M., Kokorowski, P. K., Geffner, M. E., Eugster, E. A., & on behalf of the Life with Congenital Adrenal Hyperplasia Study Group (2023) · Hormone Research in Paediatrics · doi:10.1159/000529211 · Cited by 1
Ibdah, M. G., Tos, S. M., Giacaman, N., Aljundi, A., Qabaja, M., & Salman, M. (2023) · Radiology Case Reports · doi:10.1016/j.radcr.2023.08.081 · Cited by 1
Gonadal changes in children and adolescents with congenital adrenal hyperplasia
Mahmoud, R. A. A., Abdelrahman, M. E., Mohamed, H. H., & Elsedfy, H. H. (2024) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2024-0417 · Cited by 1
Testicular adrenal rest tumors in Indonesian boys with congenital adrenal hyperplasia
Chandra, E., Utari, A., Adriaansen, B. P. H., Westra, D., Ningrum, F. H., Santoso, A. G., van Herwaarden, A. E., & der Grinten, H. L. C. (2025) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2025-0026 · Cited by 1
Current insights into monitoring of congenital adrenal hyperplasia
Leusink, Q. M., Verploegen, E., Adriaansen, B. P. H., Chin, X., Stikkelbroeck, N. M. M. L., Span, P. N., Sweep, F. C. G. J., Dona, M., van Herwaarden, A. E., & der Grinten, H. L. C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1774145 · Cited by 2
“Poor hormonal control is also associated with the development of testicular adrenal rest tumors (TARTs) (64).”
Self-citationAdriaansen, B. P. H., Utari, A., Chandra, E., Falhammar, H., Bonfig, W., Clemente, M., Lenherr‐Taube, N., Markosyan, R. L., de Miranda, M. C., Span, P. N., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag298
Self-citationIdentifying the deceiver: the non-neoplastic mimickers of genital system neoplasms
Önder, Ö., Karaosmanoğlu, A. D., Kraeft, J. J., Uysal, A., Karçaaltıncaba, M., Akata, D., Ozmen, M. N., & Hahn, P. F. (2021) · Insights into Imaging · doi:10.1186/s13244-021-01046-x · Cited by 1
“TAR is relatively common in patients with CAH and has been detected in approximately 40% of these patients [42].”
BackgroundHickman, R. A., Gionco, J. T., Faust, P. L., Miller, M. L., Bruce, J. N., Page‐Wilson, G., Rosenblum, M. K., & Asa, S. L. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12754 · Cited by 1
The prevalence of comorbid pathology in patients with type 2 diabetes mellitus
Zobova, E., Korchagina, Y. A., & Аркадьевна, В. Е. (2022) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2022-11-3-98-100 · Cited by 1
Testicular tumours in adrenogenital syndrome
Thomsen, H. H. (2024) · Ugeskrift for Læger · doi:10.61409/v12230794 · Cited by 1
Mazzeo, P., Ceccato, F., Tizianel, I., & Barbot, M. (2025) · Case Reports in Endocrinology · doi:10.1155/crie/1422782 · Cited by 2
“While infertility and TARTs are also common complications in patients with uncontrolled CAH due to 21-OHD, hypertension is typically observed in about two-thirds of patients affected by either 11 β -OHD and 17 α -hydroxylase de fi ciency [2, 3, 16].”
Pishdad, R., & Mathioudakis, N. N. (2023) · AACE Clinical Case Reports · doi:10.1016/j.aace.2023.02.002 · Cited by 1
Evaluation of Ex Vivo Adrenocorticotropic Hormone Responsiveness of Human Fetal Testis
Schröder, M. A. M., Greenald, D., Lodewijk, R., van Herwaarden, A. E., Span, P. N., Sweep, F. C. G. J., Mitchell, R. T., & der Grinten, H. L. C. (2023) · Endocrinology · doi:10.1210/endocr/bqad165
“TART may arise from fetal cells within the testis after chronic stimulation with high levels of ACTH.”
BackgroundInfluentialSelf-citationFalcetta, P., Nicolì, F., & Canale, D. (2020) · L Endocrinologo · doi:10.1007/s40619-020-00786-0
Testicular Adrenal Rest Tumours: fisiopatologia, diagnosi e trattamento
Alcubierre, D. D., Pofi, R., & Pozza, C. (2021) · L Endocrinologo · doi:10.1007/s40619-021-00816-5
Simple Virilizing 21-Hydroxylase Deficiency
Török, D., & Tõke, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-62011-0_33
Salt Wasting 21-Hydroxylase Deficiency
Török, D., & Tõke, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-62011-0_32
Fertility Treatment in Men with Classical and Nonclassical Congenital Adrenal Hyperplasia
Nigdelis, M. P., & Goulis, D. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_7
Metadata
- Authors
- Engels, M., Span, P. N., van Herwaarden, A. E., Sweep, F. C. G. J., Stikkelbroeck, N. M. M. L., & Claahsen-van der Grinten, H. L.
- Affiliations
- Radboud University Medical Center (NL)
- Radboud University Nijmegen (NL)
- Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands
- Department of Pediatrics, Amalia Children’s Hospital, Radboud University Medical Center, Nijmegen, Netherlands
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-03-18
- Volume
- 40
- Issue
- 4
- Pages
- 973-987
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2921017707
- Cited by
- 163
- References
- 102
- Citations by year
- 2026: 20 · 2025: 13 · 2024: 19 · 2023: 24 · 2022: 42 · 2021: 30 · 2020: 12 · 2019: 2
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Testicular diseases and treatments
- Keywords
- testicular adrenal rest tumor, congenital adrenal hyperplasia, tumor origin, pluripotent cells, ACTH, glucocorticoid therapy, male fertility, testicular damage, sperm cryopreservation
- MeSH terms
- Adrenal Rest Tumor, Humans, Male, Testicular Neoplasms, Gene Expression Regulation, Neoplastic, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.